Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis.
D000493:Allopurinol / Q000627:therapeutic use; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000652:urine*; D002128:Calcium Metabolism Disorders / Q000188:drug therapy; D004032:Diet; D004232:Diuretics; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D007669:Kidney Calculi / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000652:urine*; D007684:Kidney Tubules / Q000502:physiology; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D011687:Purines / Q000378:metabolism; D011859:Radiography; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014237:Trichlormethiazide / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood / Q000378:metabolism / Q000652:urine*
D004232:Diuretics; D010281:Parathyroid Hormone; D010710:Phosphates; D011687:Purines; D049993:Sodium Chloride Symporter Inhibitors; D014527:Uric Acid; D000493:Allopurinol; D014237:Trichlormethiazide; D002118:Calcium